Abstract Search

ea0032p107 | Bone and Osteoporosis | ECE2013

Resolution of anaemia after curative parathyroidectomy in a patient with primary hyperparathyroidism

Anagnostis Panagiotis , Adamidou Fotini , Agapidou Alexandra , Vakalopoulou Sofia , Garipidou Vasilia , Kita Marina

Introduction: Despite the coexistence of secondary hyperparathyroidism with anaemia, hematological manifestations of primary hyperparathyroidism (PHPT) are rare.Case report: A 67-year-old Caucasian female was admitted to the Department of Internal Medicine due to normocytic anemia and hypercalcemia, diagnosed on occasion of muscle weakness and fatigability for 3 months.Her medication included: alendronate 70 mg/week, alphacalcidol ...

0 shares

ePoster Contact

ea0032p92 | Bone and Osteoporosis | ECE2013

The effect of monthly Ibandronate on bone mineral density and bone turnover markers in patients with hemophilia A or B and increased risk for fracture

Anagnostis Panagiotis , Vyzantiadis Tomoleon-Achilleas , Charizopoulou Maria , Adamidou Fotini , Karras Spyridon , Slavakis Arisitidis , Garipidou Vasilia , Vakalopoulou Sofia

Introduction: Haemophilia A and B has been associated with increased prevalence of low bone mineral density (BMD). However, no study has so far evaluated the effects of anti-osteoporotic therapy on BMD.Methods/design: The primary endpoint of this prospective study was to estimate the effect of 12-month therapy of oral ibandronate 150 mg/month on BMD in patients with haemophilia A and B. Secondary endpoint was its effect on bone turnover markers (BTM), in...

0 shares

ePoster Contact

Endocrine Abstracts

Resolution of anaemia after curative parathyroidectomy in a patient with primary hyperparathyroidism

The effect of monthly Ibandronate on bone mineral density and bone turnover markers in patients with hemophilia A or B and increased risk for fracture

BiosciAbstracts